Shafali Spurling Jeste is professor of neurology and pediatrics at the Keck School of Medicine of the University of Southern California. She is also chief of neurology at Children’s Hospital Los Angeles (CHLA).
Shafali Spurling Jeste
Professor of neurology and pediatrics, University of Southern California;
Chief of neurology, Children’s Hospital Los Angeles
From this contributor
Leveraging the power of community to strengthen clinical trials for rare genetic syndromes
Families can become not only participants but champions of these research efforts.
Leveraging the power of community to strengthen clinical trials for rare genetic syndromes
By
Shafali Spurling Jeste
11 July 2024 | 7 min read
Telehealth may enable remote participation in autism trials
Some families do not have the financial ability or time to participate in clinical trials for autism. New technologies may enable them to participate from their homes.
Telehealth may enable remote participation in autism trials
By
Shafali Spurling Jeste
3 March 2020 | 6 min read
Reaching out to families can inspire new autism research
For students and early-career investigators, opportunities to meet and talk with the people they are trying to help underscores why the work matters.
Reaching out to families can inspire new autism research
By
Shafali Spurling Jeste
29 January 2019 | 8 min read
How treating sleep may ease all forms of autism
Behavioral interventions and medications can help children with autism-related syndromes sleep better, but the treatments must be tailored to the cause of each child’s sleep disturbance.
How treating sleep may ease all forms of autism
By
Shafali Spurling Jeste
31 October 2017 | 5 min read
Tennis program serves up benefits for children with autism
Tennis is a social game, requiring players to predict and respond to their opponent’s behavior. That may help some children with autism.
Tennis program serves up benefits for children with autism
By
Shafali Spurling Jeste
7 March 2017 | 9 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read